Open Prairie has a proven track record in fund performance and taking its portfolio investments from start to profitable exit via syndication, acquisition and IPO.  The firm currently manages three funds with combined assets of over $100 million.

  • Open Prairie Ventures I, L.P. was a $40 million (1999) fund that completed 15 investments in early-stage companies.  The fund was a top decile performer for vintage, highlighted by the IPO’s of TomoTherapy (Nasdaq:  TOMO) and InfoBlox (NYSE: BLOX) both with market caps exceeding $1 billion. 
  • Open Prairie Ventures II, L.P. is a $30 million (2008) fund that has invested in seven early-stage agricultural technology and medical device companies.  
  • Southwest Michigan Life Science Fund is a double-bottom-line fund investing in biotech, pharmaceutical, and medical device companies that complement the assets of the Kalamazoo, Michigan region.